Definitive Contract 75F40122C00193
Award Date
9/21/22
Potential Completion Date
9/29/25
Potential Value
$3.1M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Food and Drug Administration (FDA) to the University of North Carolina at Chapel Hill (UNC-CH) valued at $607,510.00. The contract, which does not have a set-aside designation, is for a project titled "Reducing Preventable Medication Errors Through Minimizing Work Distractions: Evaluating Data from Smart Pump Usage in Health Systems Across the Midwest" under BAA SSBSWP #185. UNC-CH, a prominent public research university, will be the prime...
The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract to the University of Kentucky Research Foundation, a non-profit subsidiary of the University of Kentucky, for the OPIOID STUDY KENTUCKY PMWP64 project. The contract has a potential value of $2,045,989.00 and a completion date of July 16, 2022. This contract is not set aside for any specific business designation. The University of Kentucky Research Foundation has a history of federal...
This is a $18,804,130.00 award to the University of North Carolina at Chapel Hill (UNC-CH) for the base period of the National Institute of Mental Health (NIMH) Psychoactive Drug Screening Program (PDSP). The contract provides broad-based pharmacological and functional assays to screen 2,500-3,000 samples per year against hundreds of central nervous system targets to support fundamental research on psychoactive compounds. The 5-year award has a base period from August 30, 2023 to August 29, 2024...
This $6,674.40 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-Chapel Hill). The contract is for Tier 2 analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS) of 72 macaque plasma samples. The contract has a completion date of May 15, 2024 and does not have a...
The University of North Carolina at Chapel Hill (UNC-CH), through its Office of Sponsored Research, was awarded a $4,521 firm fixed-price purchase order contract by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services. The contract, which has a completion date of November 21, 2025, is for the provision of custom adeno-associated virus (AAV) preparations to be used in experiments related to spinal circuits and...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $9,965,712.00 Other Transaction Agreement contract by the National Institutes of Health (NIH) for a project titled "CANCER SURVEILLANCE AND PRECISION HEALTH EQUITY". The contract has a period of performance through September 17, 2026. UNC-CH, as the prime contractor, will provide research and technical services to support NIH's mission in areas such as biomedical research, public health, and medical countermeasure...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services (HHS), to the University of North Carolina at Chapel Hill (UNC) for the purchase of specimens. The award was made on September 30, 2018 with a potential value of $112,266.00 and a completion date of November 30, 2020. There was no set-aside designation indicated for this contract. UNC, operating through its Office of Sponsored...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $14,727,929.36 definitive contract to the University of North Carolina at Chapel Hill (UNC) to conduct biomedical (applied/exploratory) research. The contract, which does not have a set-aside designation, runs from February 2, 2009 to July 31, 2018. As a public research university, UNC's Office of Sponsored Research provides a wide range of goods and services to the federal...
This is a $4,301.88 Firm Fixed Price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to the University of North Carolina at Chapel Hill. The order is for Tier 2 analysis by LC-MS/MS of macaque plasma samples to measure the levels of tenofovir (TFV) and emtricitabine (FTC). This work is likely in support of HIV/AIDS research at NIH. UNC-Chapel Hill has received various other prime contract awards from federal agencies for...
This firm-fixed-price purchase order contract was awarded by the Southeast Area division of a civilian federal agency to the University of North Carolina at Chapel Hill (UNC-CH) for $21,420.00. The contract is for "PROTEIN SEQUENCING SAMPLES" and has an ultimate completion date of August 10, 2022. UNC-CH, a non-profit educational institution, will provide the requested services through its Office of Sponsored Research. This contract is not set aside for any specific business type....